Exin Therapeutics, Inc., 2026-02-10
An SEC Form D private-offering notice from San Francisco, CA, a $2,162,300 filer-stated offering target in Biotech. Filed 2026-02-10. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
AI-driven drug discovery platform developing genetic therapies targeting neural circuits for neurological and neuropsychiatric disorders.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- TEN ACRES INFUSION LLC, 2026-02-11, $1M, Elk Grove, CA
- ELO LIFE SYSTEMS, INC., 2026-02-11, Durham, NC
- Reddy Solutions, Inc., 2026-02-11, $6.2M, San Francisco, CA
- Enveric Biosciences, Inc., 2026-02-11, $1.5M, Cambridge, MA
- InScope Tech, Inc., 2026-02-11, $15M, San Francisco, CA
- CytoTerra Inc., 2026-02-10, $2M, Seattle, WA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.